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Abstract
Stereotactic Ablative Body Radiotherapy (SABR) is an extension of the concepts of Stereotactic
Radiosurgery from intracranial procedures to extracranial targets. This brings with it new technological
challenges for set-up of a SABR program and continuing quality assurance. Compared with intracranial
procedures SABR requires consideration of motion and inhomogeneities and has to deal with a much
larger variety of targets ranging from lung to liver, kidney and bone. To meet many of the challenges
virtually all advances in modern radiotherapy, such as Intensity Modulated and Image Guided Radiation
Therapy (IMRT and IGRT) are used. Considering the few fractions and high doses per fraction delivered to
complex targets it is not surprising that patient specific quality control is considered essential for safe
delivery. Given the variety of targets and clinical scenarios we employ different strategies for different
patients to ensure that the most important aspects of the treatment are appropriately tested, be it steep
dose gradients, inhomogeneities or the delivery of dose in the presence of motion. The current paper
reviews the different approaches and phantoms utilised at Peter MacCallum Cancer Centre for SABR QA.
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Abstract. Stereotactic Ablative Body Radiotherapy (SABR) is an extension of the concepts of
Stereotactic Radiosurgery from intracranial procedures to extracranial targets. This brings with
it new technological challenges for set-up of a SABR program and continuing quality assurance.
Compared with intracranial procedures SABR requires consideration of motion and
inhomogeneities and has to deal with a much larger variety of targets ranging from lung to liver,
kidney and bone. To meet many of the challenges virtually all advances in modern radiotherapy,
such as Intensity Modulated and Image Guided Radiation Therapy (IMRT and IGRT) are used.
Considering the few fractions and high doses per fraction delivered to complex targets it is not
surprising that patient specific quality control is considered essential for safe delivery. Given the
variety of targets and clinical scenarios we employ different strategies for different patients to
ensure that the most important aspects of the treatment are appropriately tested, be it steep dose
gradients, inhomogeneities or the delivery of dose in the presence of motion. The current paper
reviews the different approaches and phantoms utilised at Peter MacCallum Cancer Centre for
SABR QA.

1. Introduction
Stereotactic Ablative Body Radiotherapy (SABR) is a relatively novel approach to cancer treatment
where very high doses per fraction are given to small lesions using image guidance and motion
management. SABR has become an accepted treatment modality for early stage lung cancer [1] and an
increasing number of other curative and palliative indications [2]. Compared to conventional
radiotherapy SABR features a number of challenges that require consideration for quality assurance:








Doses exceeding 10Gy per fraction
Small and possibly dynamic radiation fields
Non-coplanar beam arrangements
Inhomogeneity correction
Assessment of motion during planning
Motion management during treatment
High quality and frequent image guidance
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1.1 Typical SABR scenarios
Based on the intracranial experience, the ‘classical’ SABR scenario
is a small lesion located in a large parallel-organised critical
structure such as lung and liver. Compared to conventional
radiotherapy SABR dose distributions are often not homogenous
with high dose regions exceeding 125% of prescription dose being
not uncommon. Tight margins around the target are normal as
image guidance allows for target localisation directly prior to
treatment [3-7]. An extension of this concept is intrafraction
monitoring of tumour location, which can either be done with
radiobeacons [8, 9] or intrafraction kilovoltage monitoring (KIM)
[10].
Figure 1 illustrates typical SABR scenarios. In the case of
scenario a) the objective is to constrain the dose closely to the target
and conformity indices become an important planning tool. The
scenarios shown in figure 1b are emerging in clinical problems such
Figure 1. SABR scenarios a)
‘classical’ stereotactic problem,
as prostate SABR and the treatment of vertebral metastases on the
b) new SABR challenges
left side of the figure and lesions close to intestines or other dose
limiting structures on the right. Here steep dose gradients are
important where for quality assurance spatial resolution becomes more important than absolute dose
accuracy. Table 1 provides a summary of SABR scenarios and their specific challenges form a
dosimetric point of view.
1.2. Patient specific quality assurance
Given these considerations SABR requires both machine and patient specific quality control (QC)
activities to ensure SABR is delivered as planned. We report here on a suite of phantoms and QC
approaches that were developed specifically for patient specific SABR QC at our institution.
2. Materials and Methods
A risk analysis was performed
prior to commencing a SABR
program for early stage lung
cancer at Peter MacCallum
Cancer Centre in 2009. As
motion, small fields and
inhomogeneity
were
considered key concerns, a
Modus Quasar phantom which
includes lung inhomogeneities
was modified to allow for
various motion patterns (figure
2) [11].
Figure 2. The modified QUASAR phantom (Modus Medical)
The phantom was used
featuring inhomogeneities and a programmable motor that allows
for individual patient QC in
mimicking customised motion patterns
our institution [12] as well as
credentialing of a clinical trial
of lung SABR (CHISEL, TROG 09.02). For the latter inhomogeneity correction was tested using small
fields and the effect of motion was studied using radiochromic film [13]. It is well suited for assessment
of dose distributions in coronal or sagittal plane as the cylinder holding dosimeters (right in figure 2b)
can be rotated around a sup/inf axis. However, in some SABR applications the dose distribution in axial
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plane is required to demonstrate the steep dose gradients between target dose and spinal cord and
oesophagus. For this purpose we designed a phantom to mimic the body of a patient with the particular
aim to verify the steep dose gradients encountered in SABR of vertebral lesions. This phantom is shown
in figure 3.
Table 1. SABR applications and patient specific quality control activities
Treatment
scenario

Main challenges

Planning considerations

QC approach,
Phantom/dosimetry

Lung: early stage
curative intent

Inhomogeneity,
motion, small fields

Lung:
oligometastases

Inhomogeneity,
motion, multiple
lesions
Motion, contrast CT,
IGRT
Motion, skin dose,
IGRT
Irregular size, close to
skin (eg sternum)
Steep dose gradients
required
Irregular motion,
urethra in centre

Energy <=10MV, Field size
> 3 x 3cm2, no VMAT FFF
for single fraction
As above, limitations on
non-coplanar to limit
overlap
Gating or breath hold
considered
Consider 18MV, noncoplanar approach
Consider electron
contribution
IMRT > 9 fields
VMAT
Fiducials common, spacers,
rectal balloons

4DCT review, complex cases
measure using QUASAR
(Figure 2)
As above

Liver
Kidney
Bone metastases
Vertebral body
Prostate

4DCT review, IGRT strategy
review
4DCT review, in vivo
dosimetry for skin
Consider in vivo dosimetry
for skin
Phantom measurement using
Rod (Figure 3)
On-line imaging

Additional
SABR
Quality Control activities for
individual patients depend on
the scenario. Some important
ones are listed in table 1. In
addition to this we can utilise
an
independent
dose
calculation tool, Mobius 3D
and FX. The latter relies on
MLC
dynalog files
to
determine dose distribution in
the planning scan using a
superposition
convolution
algorithm [14].
3. Results
While the introduction of
motion did not alter the QC
results in the phantom, the
Figure 3. The ‘Rod’ phantom for SABR spine QA measurements. The
introduction
of
evaluation relies largely on radiochromic film but can also include ion
inhomogeneities as shown in chambers and TLD measurements.
figure 2, did. The initial
measurements for individual patients confirmed that the Analytical Anisotropic Algorithm (AAA) used
in the Varian Eclipse planning system has difficulties to predict the dose behind inhomogeneities
accurately [15, 16]. After the initial phase of measurements this is now only verified using an
independent monitor unit calculation and general checks of the treatment planning system.
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Given the fact that 3D conformal treatments could in general be verified without any significant
problems once the treatment couch had been taken into consideration, patient specific QC activities have
been reduced [12]. However, in the context of SABR for vertebral lesions, where Intensity Modulated
Radiation Therapy is essential, every patient treatment is still verified using physical measurements prior
to treatment. For this an ionisation chamber measurement and a radiochromic film assessment in the
“Rod” phantom shown in figure 3 is routinely performed. It is particularly the dose distribution recorded
on the film as shown in figure 3 on the right which informs the acceptability of the plan. The steep dose
gradient in both plan and treatment verification film can be clearly seen and a 1mm distance to
agreement criterion is typically used for evaluation.
4. Discussion and Conclusion
For the wide variety of SABR applications no single phantom appears to be suitable for individual
patient QC as different treatment approaches require visualisation of dose distributions in different
planes with high spatial resolution. In addition to ionisation chambers measurements radiochromic film
was found to be essential for most of the measurements. Future work will be directed to studying real
time dosimeters with high spatial resolution such as the dose magnifying glass [17] as replacement to
shorten the turn around time for QC measurements.
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